Trump calls for reductions in pharmaceutical prices
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid. Read More »
As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »
A clear plurality (almost half) of American consumers blame drug makers for high drug costs, according to a new Google Consumer Survey conducted for American Pharmacy News. Read More »
President Donald Trump said before winning the election that the Affordable Care Act was one of the top items to be eliminated when he took office. Read More »
A new drug formulary that will allow cancer centers to access approved and investigational drugs for the use of preclinical and clinical studies in cancer treatment has been launched by the National Cancer Institute. Read More »
A measure to allow pharmacists a greater role in rural patient’s health care maintenance has been introduced to the U.S. Senate. Read More »
Robert Kennedy Jr. has announced he will chair President Donald Trump's new commission on vaccine safety. Read More »
A final rule issued by the Department of Health and Human Services allows pharmacies increased flexibility to extend reward and loyalty programs to patients enrolled in government-sponsored programs like Medicare and Medicaid. Read More »
An Illinois-based pharmacy group is leading the charge for an antimicrobial therapy timeout initiative, in response to a joint commission mandate. Read More »
The National Institute of Allergy and Infectious Diseases recently released new guidelines to help health care providers and family members manage and prevent peanut allergies in infants. Read More »
A recent Centers for Disease Control and Prevention report showed the challenges rural health care faces and the need for provider status legislation. Read More »
Members of the American Pharmacists Association submitted a joint statement to President Donald Trump's administration, asking for an appeal to a recent U.S. Food and Drug Administration decision saying a pharmacist cannot begin to fill a patient’s prescription without a written, valid prescription on hand. Read More »
Dealing with the thorny, and often contentious, issue of drug prices is likely to be front and center in the early days of the new Trump administration. Arriving at a solution to curb increasing costs will be a delicate balance for all those with a stake in the issue, according to a leading health economist. Read More »
New legislation for Medicare Part B beneficiaries has recently been reintroduced to the Senate to give underserved communities access to pharmacist-provided care. Read More »
New data released by the Department of Health and Human Services shows that adults with disabilities on Medicare continue to save on prescriptions, and that there has been an increase in benefits from last year as a result of the Affordable Care Act. Read More »
A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
The public relations departments at American pharmaceutical manufacturers can’t be too pleased about the results of a new Harris Poll out this week that shows only nine percent of U.S. consumers believe “pharmaceutical and biotechnology companies put patients over profits.” Read More »